Bayer Files Patent Infringement Suit Against Watson Over Yaz Generics
This article was originally published in The Pink Sheet Daily
Executive Summary
Watson follows Barr in filing ANDA paragraph IV certification against Yaz patent.
You may also be interested in...
Court Finds Bayer’s Yasmin Oral Contraceptive Patent Is Invalid
A district court ruling against Bayer’s oral contraceptive patent opens the way for Barr to launch a generic version of Yasmin.
Court Finds Bayer’s Yasmin Oral Contraceptive Patent Is Invalid
A district court ruling against Bayer’s oral contraceptive patent opens the way for Barr to launch a generic version of Yasmin.
Bayer, Intendis To Copromote Yaz For Acne/Birth Control Indication
Bayer leverages Intendis sales force to promote new dermatology indication for oral contraceptive, firm tells “The Pink Sheet” DAILY.